Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)
ConditionNMOSD
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXiamen Hospital of Traditional Chinese Medicine
About this trial
This study aims to characterize sex hormone alterations and their potential clinical significance in NMOSD patients from Southern China through comprehensive hormonal profiling.
Eligibility criteria
Qualifiers
Aged 18 years or older, regardless of sex
Fulfilled the diagnostic criteria for Neuromyelitis Optica Spectrum Disorders as defined by the 2021 Chinese guidelines for the diagnosis and management of NMOSD
Seropositive for AQP4-IgG
Provided informed consent by the participant or their legal guardian
Disqualifiers
Diagnosis of other serious systemic diseases (e.g., malignancy)
Presence of severe psychiatric disorders that would preclude compliance with study procedures and/or follow-up assessments
History of infectious pathologies of the central nervous system
Those with severe liver and kidney function impairment or dysfunction of other vital organs
Trial design
Treatments tested in this trial
- Sex hormone assay
- Sex hormone assay
Treatment groups
4,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov